Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 100

1.

Randomized controlled trial of cognitive behavioral therapy vs standard treatment to prevent recurrent cardiovascular events in patients with coronary heart disease: Secondary Prevention in Uppsala Primary Health Care project (SUPRIM).

Gulliksson M, Burell G, Vessby B, Lundin L, Toss H, Svärdsudd K.

Arch Intern Med. 2011 Jan 24;171(2):134-40. doi: 10.1001/archinternmed.2010.510.

PMID:
21263103
[PubMed - indexed for MEDLINE]
2.

Stress reduction in the secondary prevention of cardiovascular disease: randomized, controlled trial of transcendental meditation and health education in Blacks.

Schneider RH, Grim CE, Rainforth MV, Kotchen T, Nidich SI, Gaylord-King C, Salerno JW, Kotchen JM, Alexander CN.

Circ Cardiovasc Qual Outcomes. 2012 Nov;5(6):750-8. doi: 10.1161/CIRCOUTCOMES.112.967406. Epub 2012 Nov 13.

PMID:
23149426
[PubMed - indexed for MEDLINE]
Free Article
3.

Global secondary prevention strategies to limit event recurrence after myocardial infarction: results of the GOSPEL study, a multicenter, randomized controlled trial from the Italian Cardiac Rehabilitation Network.

Giannuzzi P, Temporelli PL, Marchioli R, Maggioni AP, Balestroni G, Ceci V, Chieffo C, Gattone M, Griffo R, Schweiger C, Tavazzi L, Urbinati S, Valagussa F, Vanuzzo D; GOSPEL Investigators.

Arch Intern Med. 2008 Nov 10;168(20):2194-204. doi: 10.1001/archinte.168.20.2194.

PMID:
19001195
[PubMed - indexed for MEDLINE]
5.

Association of diet, exercise, and smoking modification with risk of early cardiovascular events after acute coronary syndromes.

Chow CK, Jolly S, Rao-Melacini P, Fox KA, Anand SS, Yusuf S.

Circulation. 2010 Feb 16;121(6):750-8. doi: 10.1161/CIRCULATIONAHA.109.891523. Epub 2010 Feb 1.

PMID:
20124123
[PubMed - indexed for MEDLINE]
Free Article
6.

Effect of xuezhikang on cardiovascular events and mortality in elderly patients with a history of myocardial infarction: a subgroup analysis of elderly subjects from the China Coronary Secondary Prevention Study.

Ye P, Lu ZL, Du BM, Chen Z, Wu YF, Yu XH, Zhao YC; CCSPS Investigators.

J Am Geriatr Soc. 2007 Jul;55(7):1015-22.

PMID:
17608873
[PubMed - indexed for MEDLINE]
7.

[Efficacy of an intensive prevention programme of coronary heart disease: 5 year follow-up outcomes].

Muñoz MA, Subirana I, Ramos R, Franzi A, Vila J, Marrugat J; estudio ICAR investigators (Intervención en la Comunidad de Alto Riesgo coronario).

Med Clin (Barc). 2008 Apr 19;130(14):521-5. Spanish.

PMID:
18457617
[PubMed - indexed for MEDLINE]
8.

Kidney disease as a risk factor for recurrent cardiovascular disease and mortality.

Weiner DE, Tighiouart H, Stark PC, Amin MG, MacLeod B, Griffith JL, Salem DN, Levey AS, Sarnak MJ.

Am J Kidney Dis. 2004 Aug;44(2):198-206.

PMID:
15264177
[PubMed - indexed for MEDLINE]
9.

Effects of antidepressant medication on morbidity and mortality in depressed patients after myocardial infarction.

Taylor CB, Youngblood ME, Catellier D, Veith RC, Carney RM, Burg MM, Kaufmann PG, Shuster J, Mellman T, Blumenthal JA, Krishnan R, Jaffe AS; ENRICHD Investigators.

Arch Gen Psychiatry. 2005 Jul;62(7):792-8.

PMID:
15997021
[PubMed - indexed for MEDLINE]
10.

Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction: final report of the Lyon Diet Heart Study.

de Lorgeril M, Salen P, Martin JL, Monjaud I, Delaye J, Mamelle N.

Circulation. 1999 Feb 16;99(6):779-85.

PMID:
9989963
[PubMed - indexed for MEDLINE]
Free Article
11.

Benefits of pravastatin on cardiovascular events and mortality in older patients with coronary heart disease are equal to or exceed those seen in younger patients: Results from the LIPID trial.

Hunt D, Young P, Simes J, Hague W, Mann S, Owensby D, Lane G, Tonkin A.

Ann Intern Med. 2001 May 15;134(10):931-40.

PMID:
11352694
[PubMed - indexed for MEDLINE]
12.

Effects of treating depression and low perceived social support on clinical events after myocardial infarction: the Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) Randomized Trial.

Berkman LF, Blumenthal J, Burg M, Carney RM, Catellier D, Cowan MJ, Czajkowski SM, DeBusk R, Hosking J, Jaffe A, Kaufmann PG, Mitchell P, Norman J, Powell LH, Raczynski JM, Schneiderman N; Enhancing Recovery in Coronary Heart Disease Patients Investigators (ENRICHD).

JAMA. 2003 Jun 18;289(23):3106-16.

PMID:
12813116
[PubMed - indexed for MEDLINE]
13.

Psychosocial treatment within sex by ethnicity subgroups in the Enhancing Recovery in Coronary Heart Disease clinical trial.

Schneiderman N, Saab PG, Catellier DJ, Powell LH, DeBusk RF, Williams RB, Carney RM, Raczynski JM, Cowan MJ, Berkman LF, Kaufmann PG; ENRICHD Investigators.

Psychosom Med. 2004 Jul-Aug;66(4):475-83.

PMID:
15272091
[PubMed - indexed for MEDLINE]
14.

Rationale and design of a secondary prevention trial of lowering normal plasma cholesterol levels after acute myocardial infarction: the Cholesterol and Recurrent Events trial (CARE)

Sacks FM, Pfeffer MA, Moye' L, Brown LE, Hamm P, Cole TG, Hawkins CM, Braunwald E.

Am J Cardiol. 1991 Dec 1;68(15):1436-46. Erratum in: Am J Cardiol 1992 Feb 15;69(5):574.

PMID:
1746424
[PubMed - indexed for MEDLINE]
15.

Long-term outcome of the Malmö preventive project: mortality and cardiovascular morbidity.

Berglund G, Nilsson P, Eriksson KF, Nilsson JA, Hedblad B, Kristenson H, Lindgärde F.

J Intern Med. 2000 Jan;247(1):19-29.

PMID:
10672127
[PubMed - indexed for MEDLINE]
16.

Impact of coronary artery stents on mortality and nonfatal myocardial infarction: meta-analysis of randomized trials comparing a strategy of routine stenting with that of balloon angioplasty.

Al Suwaidi J, Holmes DR Jr, Salam AM, Lennon R, Berger PB.

Am Heart J. 2004 May;147(5):815-22.

PMID:
15131536
[PubMed - indexed for MEDLINE]
17.

Multiple risk factor intervention trial revisited: a new perspective based on nonfatal and fatal composite endpoints, coronary and cardiovascular, during the trial.

Stamler J, Neaton JD, Cohen JD, Cutler J, Eberly L, Grandits G, Kuller LH, Ockene J, Prineas R; MRFIT Research Group.

J Am Heart Assoc. 2012 Oct;1(5):e003640. doi: 10.1161/JAHA.112.003640. Epub 2012 Oct 25.

PMID:
23316301
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Coronary heart disease mortality and adjuvant tamoxifen therapy.

Costantino JP, Kuller LH, Ives DG, Fisher B, Dignam J.

J Natl Cancer Inst. 1997 Jun 4;89(11):776-82.

PMID:
9182975
[PubMed - indexed for MEDLINE]
Free Article
19.

Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial.

Keech A, Simes RJ, Barter P, Best J, Scott R, Taskinen MR, Forder P, Pillai A, Davis T, Glasziou P, Drury P, Kesäniemi YA, Sullivan D, Hunt D, Colman P, d'Emden M, Whiting M, Ehnholm C, Laakso M; FIELD study investigators.

Lancet. 2005 Nov 26;366(9500):1849-61. Erratum in: Lancet. 2006 Oct 21;368(9545):1415. Lancet. 2006 Oct 21;368(9545):1420.

PMID:
16310551
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk